Suppression of tumorigenicity in somatic cell hybrids. IV. Chromosomes of normal human cells associated with suppression of tumorigenicity in hybrids with D98AH2 carcinoma cells
- PMID: 3463446
- DOI: 10.1159/000132283
Suppression of tumorigenicity in somatic cell hybrids. IV. Chromosomes of normal human cells associated with suppression of tumorigenicity in hybrids with D98AH2 carcinoma cells
Abstract
An analysis for cosegregation of chromosomes and tumorigenicity in 52 hybrids of human diploid X D98AH2 human carcinoma-derived cells reveals the consistent presence of four copies of chromosome 11 in all nontumorigenic hybrids (two from each of the parental cells) and a consistent loss of one or two copies of the 11 in all tumor cells derived from tumorigenic hybrids that grow in nude mice. In our earlier study, assays with restriction fragment length polymorphic (RFLP) markers for the cell parent origin of the chromosomes 11 in the hybrids indicated that at least one of the Nos. 11 lost in the tumor cells is from the diploid. Thus both Nos. 11 of the diploid seem to be required for complete and stable suppression of the tumorigenic phenotype. The results of the present study suggest that chromosome 2 may also carry suppressor information, but this causes only partial suppression of the tumorigenic phenotype in the absence of both Nos. 11. On the other hand, when the hybrids contain full complements of the 2 and the 11, suppression is very stable. All other chromosomes except for Nos. 1, 16, 17, 19, and 21 are clearly discordant with suppression. The latter chromosomes are not discordant often enough to allow their exclusion as possible carriers of suppressor information, particularly in the absence of RFLP evaluations. It is clear, however, that if they do carry such information it is not adequate for maintaining a stably suppressed phenotype in the absence of both Nos. 11 of the diploid.
Similar articles
-
Levels of fos, ets2, and myb proto-oncogene RNAs correlate with segregation of chromosome 11 of normal cells and with suppression of tumorigenicity in human cell hybrids.Mol Cell Biol. 1987 Aug;7(8):2941-6. doi: 10.1128/mcb.7.8.2941-2946.1987. Mol Cell Biol. 1987. PMID: 3670301 Free PMC article.
-
Suppression of tumorigenicity in somatic cell hybrids. III. Cosegregation of human chromosome 11 of a normal cell and suppression of tumorigenicity in intraspecies hybrids of normal diploid x malignant cells.Cytogenet Cell Genet. 1986;41(2):65-70. doi: 10.1159/000132206. Cytogenet Cell Genet. 1986. PMID: 3956263
-
Suppression of tumorigenicity in somatic cell hybrids. II. Human chromosomes implicated as suppressors of tumorigenicity in hybrids with Chinese hamster ovary cells.J Natl Cancer Inst. 1983 Sep;71(3):559-69. J Natl Cancer Inst. 1983. PMID: 6577230
-
Suppression of tumorigenicity in hybrids of tumorigenic Chinese hamster cells and diploid mouse fibroblasts: dependence on the presence of at least three different mouse chromosomes and independence of hamster genome dosage.Cancer Res. 1983 May;43(5):2240-6. Cancer Res. 1983. PMID: 6831446
-
Cell-Cell Fusion and the Roads to Novel Properties of Tumor Hybrid Cells.Cells. 2021 Jun 11;10(6):1465. doi: 10.3390/cells10061465. Cells. 2021. PMID: 34207991 Free PMC article. Review.
Cited by
-
Levels of fos, ets2, and myb proto-oncogene RNAs correlate with segregation of chromosome 11 of normal cells and with suppression of tumorigenicity in human cell hybrids.Mol Cell Biol. 1987 Aug;7(8):2941-6. doi: 10.1128/mcb.7.8.2941-2946.1987. Mol Cell Biol. 1987. PMID: 3670301 Free PMC article.
-
Construction of mouse A9 clones containing a single human chromosome (X/autosome translocation) via micro-cell fusion.Jpn J Cancer Res. 1989 Feb;80(2):122-5. doi: 10.1111/j.1349-7006.1989.tb02278.x. Jpn J Cancer Res. 1989. PMID: 2498246 Free PMC article.
-
Nonrandom duplication of the chromosome bearing a mutated Ha-ras-1 allele in mouse skin tumors.Proc Natl Acad Sci U S A. 1990 Sep;87(17):6902-6. doi: 10.1073/pnas.87.17.6902. Proc Natl Acad Sci U S A. 1990. PMID: 1697691 Free PMC article.
-
Molecular nature of genetic changes resulting in loss of heterozygosity of chromosome 11 in Wilms' tumours.Hum Genet. 1988 Dec;81(1):41-8. doi: 10.1007/BF00283727. Hum Genet. 1988. PMID: 2848758
-
Alterations of chromosome 11q13 in cervical carcinoma cell lines.Am J Hum Genet. 1996 Feb;58(2):422-5. Am J Hum Genet. 1996. PMID: 8571970 Free PMC article. No abstract available.